Several companies in the healthcare and cannabis sectors have reported their financial results for the first quarter of 2025, including Nutex Health, Glass House Brands, and Grown Rogue International. Nutex Health reported total revenue of $211.8 million for Q1 2025, a 213.8% increase from $67.5 million in Q1 2024. The company posted net income attributable to Nutex Health of $14.6 million, diluted EPS of $2.56, and operating income of $72.2 million. EBITDA rose to $43.1 million, and adjusted EBITDA reached $72.8 million. The revenue increase was largely driven by arbitration recoveries, and the company reported a cash balance of $87.7 million. Glass House Brands reported first quarter 2025 revenue of $44.8 million, up 49% year-over-year. Gross profit was $20.1 million, and gross margin improved to 45%. Wholesale biomass production grew 149% to 152,568 pounds, with the cost of production dropping to $108 per pound from $182 the previous year. Adjusted EBITDA was $4.4 million, and the company ended the quarter with $37.6 million in cash and restricted cash. Glass House secured a new $50 million senior secured credit facility. Grown Rogue International reported pro forma revenue of $7.15 million for Q1 2025, up 7% year-over-year, and pro forma adjusted EBITDA of $1.57 million. The company's New Jersey affiliate, ABCO Garden State, contributed $1.77 million in revenue and $0.77 million in adjusted EBITDA, with a margin of 43.4%. In Oregon and Michigan, Grown Rogue maintained adjusted EBITDA margins of 34.1% and 36.4%, with costs per pound of $414 and $430, respectively. Other companies such as Innate Pharma also released their quarterly results, with Innate Pharma highlighting progress in its clinical portfolio and partnerships, and maintaining a cash position of €72.5 million as of March 31, 2025.